Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound – The Wall Street Journal

Shares in Novo Nordisk were down 14% in European midday trading

#stockmarket #breaking

Leave a Reply

WP Twitter Auto Publish Powered By : XYZScripts.com